|
Real-time Estimate
Cboe BZX
22:42:12 19/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 11.13 USD | +4.90% |
|
-2.05% | -46.12% |
| 08-11 | BofA Securities Adjusts Keros Therapeutics Price Target to $17 From $20 | MT |
| 08-03 | Keros Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.90% | -2.05% | +3.39% | +10.70% | -46.12% | -24.29% | -69.20% | -64.06% | - | 210M | |
| -1.90% | +2.37% | +39.11% | +60.71% | +80.94% | +69.11% | +110.88% | +27.51% | - | 73.45B | |
| +0.87% | +15.32% | +16.45% | +28.12% | +22.43% | +56.99% | +92.41% | +228.57% | +6,400.74% | 62.99B | |
| +0.63% | -2.49% | +20.53% | +20.09% | -25.88% | +1.40% | +486.32% | +474.31% | +914.87% | 28.05B | |
| -1.40% | +4.18% | +29.53% | +45.42% | +52.35% | +54.52% | +19.60% | -57.46% | - | 25.42B | |
| +20.43% | +20.61% | +21.37% | +27.41% | +17.49% | +0.40% | -4.83% | -66.29% | - | 23.3B | |
| +2.28% | +5.65% | +16.51% | +29.87% | +6.17% | +42.00% | -13.75% | -27.52% | +94.05% | 19.45B | |
| 0.00% | -4.11% | +17.15% | +92.68% | +230.42% | +243.99% | +423.83% | +1,733.40% | +857.44% | 18.16B | |
| -3.50% | -0.95% | +7.63% | +23.41% | +33.48% | +17.17% | +534.55% | - | - | 16.53B | |
| +2.32% | +8.06% | -1.96% | +11.86% | +24.21% | +45.10% | +154.75% | +206.01% | +394.91% | 13.16B | |
| +1.75% | +2.53% | +24.86% | +22.25% | +34.75% | +350.45% | +211.92% | +53.24% | +1,092.80% | 12.42B | |
| +3.16% | +0.62% | +0.71% | +5.41% | -7.36% | +42.14% | +200.77% | +584.82% | +5,719.85% | 12.12B | |
| -1.87% | -12.37% | +1.08% | -21.53% | -20.97% | -47.99% | +174.77% | +117.01% | - | 10.69B | |
| +2.16% | +2.84% | -1.67% | +1.75% | +22.43% | +105.58% | +136.16% | +159.30% | +560.92% | 10.58B | |
| +2.50% | -13.31% | -3.04% | -17.41% | -25.16% | -48.36% | +581.77% | +82.82% | +91.94% | 10.23B | |
| +1.66% | +4.79% | +12.07% | +63.73% | +232.97% | +577.09% | +772.81% | -37.76% | -15.44% | 9.51B | |
| -1.52% | -6.87% | +2.23% | -9.15% | +8.26% | -3.05% | +118.65% | -26.11% | - | 9.1B | |
| +0.03% | +0.34% | +1.05% | +142.56% | +82.06% | +187.97% | +428.04% | +297.89% | - | 8.99B | |
| +6.59% | +6.16% | +14.10% | +29.82% | +37.25% | +99.57% | +27.39% | +212.56% | - | 8.9B | |
| +5.25% | +4.65% | +8.07% | +4.38% | +309.09% | +255.26% | +392.40% | -11.67% | - | 8.18B | |
| Average | +2.18% | -0.15% | +11.46% | +28.60% | +53.44% | +101.25% | +238.96% | +204.56% | +1,611.21% | 19.07B | |
| Weighted average by Cap. | +1.52% | +2.45% | +18.57% | +35.27% | +51.19% | +82.10% | +200.12% | +207.66% | +2,751.11% |
- Stock Market
- Stocks
- KROS Stock
- Sector Keros Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
